Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity
- PMID: 23595986
- PMCID: PMC3668731
- DOI: 10.1074/jbc.M113.460212
Targeted deletion of growth hormone (GH) receptor in macrophage reveals novel osteopontin-mediated effects of GH on glucose homeostasis and insulin sensitivity in diet-induced obesity
Abstract
We investigated GH action on macrophage (MΦ) by creating a MΦ-specific GH receptor-null mouse model (MacGHR KO). On a normal diet (10% fat), MacGHR KO and littermate controls exhibited similar growth profiles and glucose excursions on intraperitoneal glucose (ipGTT) and insulin tolerance (ITT) tests. However, when challenged with high fat diet (HFD, 45% fat) for 18 weeks, MacGHR KO mice exhibited impaired ipGTT and ITT compared with controls. In MacGHR KO, adipose-tissue (AT) MΦ abundance was increased with skewing toward M1 polarization. Expression of pro-inflammatory cytokines (IL1β, TNF-α, IL6, and osteopontin (OPN)) were increased in MacGHR KO AT stromal vascular fraction (SVF). In MacGHR KO AT, crown-like-structures were increased with decreased insulin-dependent Akt phosphorylation. The abundance of phosphorylated NF-κB and of OPN was increased in SVF and bone-marrow-derived MΦ in MacGHR KO. GH, acting via an NF-κB site in the distal OPN promoter, inhibited the OPN promoter. Thus in diet-induced obesity (DIO), lack of GH action on the MΦ exerts an unexpected deleterious effect on glucose homeostasis by accentuating AT inflammation and NF-κB-dependent activation of OPN expression. These novel results in mice support the possibility that administration of GH could have salutary effects on DIO-associated chronic inflammation and insulin resistance in humans.
Keywords: Adipose Tissue; Growth Hormone; Inflammation; Macrophages; Obesity.
Figures








Similar articles
-
Osteopontin is required for the early onset of high fat diet-induced insulin resistance in mice.PLoS One. 2010 Nov 12;5(11):e13959. doi: 10.1371/journal.pone.0013959. PLoS One. 2010. PMID: 21103061 Free PMC article.
-
Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice.PLoS One. 2014 May 28;9(5):e98398. doi: 10.1371/journal.pone.0098398. eCollection 2014. PLoS One. 2014. PMID: 24871103 Free PMC article.
-
FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity.Metabolism. 2018 Jun;83:31-41. doi: 10.1016/j.metabol.2018.01.013. Epub 2018 Jan 31. Metabolism. 2018. PMID: 29374559
-
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance.Biochim Biophys Acta. 2014 Mar;1842(3):446-62. doi: 10.1016/j.bbadis.2013.05.017. Epub 2013 May 22. Biochim Biophys Acta. 2014. PMID: 23707515 Free PMC article. Review.
-
The Modulatory Role of Growth Hormone in Inflammation and Macrophage Activation.Endocrinology. 2022 Aug 1;163(8):bqac088. doi: 10.1210/endocr/bqac088. Endocrinology. 2022. PMID: 35695371 Review.
Cited by
-
Developmental Programming: Prenatal Testosterone Excess and Insulin Signaling Disruptions in Female Sheep.Biol Reprod. 2016 May;94(5):113. doi: 10.1095/biolreprod.115.136283. Epub 2016 Apr 6. Biol Reprod. 2016. PMID: 27053365 Free PMC article.
-
Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles.Endocrinology. 2014 May;155(5):1793-805. doi: 10.1210/en.2013-2086. Epub 2014 Feb 11. Endocrinology. 2014. PMID: 24517230 Free PMC article.
-
Non-pituitary GH regulation of the tissue microenvironment.Endocr Relat Cancer. 2023 Jun 1;30(7):e230028. doi: 10.1530/ERC-23-0028. Print 2023 Jul 1. Endocr Relat Cancer. 2023. PMID: 37066857 Free PMC article.
-
Early Life Nociception is Influenced by Peripheral Growth Hormone Signaling.J Neurosci. 2021 May 19;41(20):4410-4427. doi: 10.1523/JNEUROSCI.3081-20.2021. Epub 2021 Apr 22. J Neurosci. 2021. PMID: 33888610 Free PMC article.
-
Osteopontin: A novel regulator at the cross roads of inflammation, obesity and diabetes.Mol Metab. 2014 Mar 22;3(4):384-93. doi: 10.1016/j.molmet.2014.03.004. eCollection 2014 Jul. Mol Metab. 2014. PMID: 24944898 Free PMC article. Review.
References
-
- Newbern D., Freemark M. (2011) Placental hormones and the control of maternal metabolism and fetal growth. Curr. Opin. Endocrinol. Diabetes Obes. 18, 409–416 - PubMed
-
- Bloch C. A., Clemons P., Sperling M. A. (1987) Puberty decreases insulin sensitivity. J. Pediatr. 110, 481–487 - PubMed
-
- Clayton P. E., Cowell C. T. (2000) Safety issues in children and adolescents during growth hormone therapy–a review. Growth Horm IGF Res. 10, 306–317 - PubMed
-
- Møller N., Jørgensen J. O. (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr. Rev. 30, 152–177 - PubMed
-
- Johansen T., Laurino C., Barreca A., Malmlöf K. (2005) Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling. Growth Horm IGF Res. 15, 55–63 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials